Abstract
controls (c (1) 1⁄4 7.24, p 2-fold more patients achieving recommended target LDL-c levels. This could have major implications for prevention of cardiovascular disease in Canada. AstraZeneca
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have